In an industry-wide insider-trading investigation, prosecutors have begun examining expert-network firms and others. With that probe, “We think the investor clients are going to really withdraw quite a but” from the company’s healthcare network, said Leerink executive Jeffrey Aroy.
However, it is not clear whether investigators in the insider-trading probe are examining Leerink or its consultants.
Read the Wall Street Journal report on industry relationships.
–Physicians’ Links to Devicemakers, Pharma Declined 2004-2009
–Trends, Developments and Legal Issues in the Orthopedic and Spine Device Markets
–Five Trends and Developments Affecting the Orthopedic and Spine Device Market
At Becker's 4th Annual CEO + CFO Roundtable, taking place November 2–5 in Chicago, more than 1,500 hospital and health system executives tackle decisions that determine whether organizations thrive or merely survive: protecting margins under cost pressure, choosing where to grow, renegotiating payer relationships, stabilizing the workforce and proving real ROI on technology. This is where leaders work through them together, face-to-face. Apply for complimentary registration now.
